Growth Metrics

Quest Diagnostics (DGX) Short term Debt (2016 - 2025)

Historic Short term Debt for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $504.0 million.

  • Quest Diagnostics' Short term Debt fell 1641.79% to $504.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $504.0 million, marking a year-over-year decrease of 1641.79%. This contributed to the annual value of $602.0 million for FY2024, which is 9867.99% up from last year.
  • As of Q3 2025, Quest Diagnostics' Short term Debt stood at $504.0 million, which was down 1641.79% from $504.0 million recorded in Q2 2025.
  • Quest Diagnostics' 5-year Short term Debt high stood at $906.0 million for Q1 2024, and its period low was $1.0 million during Q3 2021.
  • Over the past 5 years, Quest Diagnostics' median Short term Debt value was $2.0 million (recorded in 2021), while the average stood at $256.2 million.
  • Its Short term Debt has fluctuated over the past 5 years, first surged by 4520000.0% in 2024, then tumbled by 9988.96% in 2025.
  • Quarter analysis of 5 years shows Quest Diagnostics' Short term Debt stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then skyrocketed by 15050.0% to $303.0 million in 2023, then soared by 98.68% to $602.0 million in 2024, then dropped by 16.28% to $504.0 million in 2025.
  • Its last three reported values are $504.0 million in Q3 2025, $504.0 million for Q2 2025, and $1.0 million during Q1 2025.